Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001983055 | SCV002244597 | pathogenic | Carnitine palmitoyltransferase II deficiency | 2021-10-14 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with CPT2-related conditions. This sequence change creates a premature translational stop signal (p.Arg303Glyfs*8) in the CPT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CPT2 are known to be pathogenic (PMID: 16781677, 16996287). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003475259 | SCV004211070 | likely pathogenic | Encephalopathy, acute, infection-induced, susceptibility to, 4 | 2023-06-24 | criteria provided, single submitter | clinical testing |